Close Menu

stock offering

NEW YORK (GenomeWeb News) – Pressure BioSciences has filed with US regulators for a direct offering of a maximum of $5 million of its Series F preferred stock.

NEW YORK (GenomeWeb News) – Rosetta Genomics today said that it has entered into definitive agreements with investors to purchase $2.2 million worth of its stock.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Complete Genomics today announced an agreement with investment bank MLV & Co. for the potential sale of an aggregate of $30 million of its common stock.

Alnylam to Sell $86.9M in Stock

Premium

Alnylam Pharmaceuticals this week announced that it would offer for sale 8.625 million of its shares at $10.75 per share.
The company's shares have been trading around $12.50 this week.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Sequenom has launched a public offering of 13 million shares of common stock priced at $4.15 per share.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Complete Genomics has filed to raise up to $100 million in a public offering.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Exact Sciences today said that it has raised net proceeds of $27.1 million in a public offering of common stock.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Pressure BioSciences on Monday filed a preliminary registration form with the US Securities and Exchange Commission to raise up to $8 million.

By a GenomeWeb staff reporter
NEW YORK (GenomeWeb News) – Response Biomedical this week said it has filed the final prospectus for its offering to raise C$8 million (US$7.9 million).

Pages

The Washington Post reports on researchers' efforts to determine the effect of an increasingly common SARS-CoV-2 mutation.

Florida Politics reports Florida's law barring life, long-term care, and disability insurers from using genetic information in coverage decisions went into effect at the beginning of July.

A new analysis finds a link between popular media coverage of a scientific study and how often that paper is cited.

In Nature this week: CRISPR approaches to editing plant genomes, way to speed up DNA-PAINT, and more.